Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Emmerich

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 13, 1990
[Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type]R Schlag, D Flieger, H W Ziegler-Heitbrock, et al.
Leukemia|July 1, 1989
T cell receptor alpha expression in B-type chronic lymphocytic leukemiaK Pachmann, A Raghavachar, C Bartram, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapyC M Wendtner, B Schmitt, M Wilhelm, et al.
European Journal of Medical Research|March 24, 1997
Particulate ANP-sensitive guanylyl cyclase in blood and bone marrow cells of patients with acute leukemiaB Knau, C Sturm, J M Heim, et al.
British Journal of Haematology|July 1, 1997
Liposomal 1,25 (OH)2 vitamin D3 compounds block proliferation and induce differentiation in myelomonocytic leukaemia cellsM Frankenberger, B Hofmann, B Emmerich, et al.
British Journal of Haematology|February 1, 1995
Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cellsR Dengler, U Münstermann, S al-Batran, et al.
Cancer|June 15, 1994
Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trialS Adler, S Lang, I Langenmayer, et al.
Infection and Immunity|September 20, 2021
Novel Murine Pancreatic Tumor Model Demonstrates Immunotherapeutic Control of Tumor Progression by a Toxoplasma gondii ProteinSusan N Payne, Philip B Emmerich, Nicole M Davis, et al.
Bone Marrow Transplantation|September 1, 1996
Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSFM Mitterer, J Hirber, I Gentilini, et al.
Annals of Hematology|May 10, 2000
The activation of intracellular tyrosine kinases by interferon-alpha (IFNalpha) correlates with its antiproliferative activity in B-lymphoid cell lines, but not in B-cell chronic lymphocytic leukemia patientsN von Bubnoff, S Adler, S Danhauser-Riedl, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Deutsche Medizinische Wochenschrift (1946)|July 13, 1990
[Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type]R Schlag, D Flieger, H W Ziegler-Heitbrock, et al.
Leukemia|July 1, 1989
T cell receptor alpha expression in B-type chronic lymphocytic leukemiaK Pachmann, A Raghavachar, C Bartram, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapyC M Wendtner, B Schmitt, M Wilhelm, et al.
European Journal of Medical Research|March 24, 1997
Particulate ANP-sensitive guanylyl cyclase in blood and bone marrow cells of patients with acute leukemiaB Knau, C Sturm, J M Heim, et al.
British Journal of Haematology|July 1, 1997
Liposomal 1,25 (OH)2 vitamin D3 compounds block proliferation and induce differentiation in myelomonocytic leukaemia cellsM Frankenberger, B Hofmann, B Emmerich, et al.
British Journal of Haematology|February 1, 1995
Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cellsR Dengler, U Münstermann, S al-Batran, et al.
Cancer|June 15, 1994
Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trialS Adler, S Lang, I Langenmayer, et al.
Infection and Immunity|September 20, 2021
Novel Murine Pancreatic Tumor Model Demonstrates Immunotherapeutic Control of Tumor Progression by a Toxoplasma gondii ProteinSusan N Payne, Philip B Emmerich, Nicole M Davis, et al.
Bone Marrow Transplantation|September 1, 1996
Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSFM Mitterer, J Hirber, I Gentilini, et al.
Annals of Hematology|May 10, 2000
The activation of intracellular tyrosine kinases by interferon-alpha (IFNalpha) correlates with its antiproliferative activity in B-lymphoid cell lines, but not in B-cell chronic lymphocytic leukemia patientsN von Bubnoff, S Adler, S Danhauser-Riedl, et al.
Pageof 15